These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1204793)

  • 1. Conformations and biological properties of apomorphine and its phenanthro(10,1-b,c)azepine homologue.
    Berney D; Petcher TJ; Schmutz J; Weber HP; White TG
    Experientia; 1975 Nov; 31(11):1327-8. PubMed ID: 1204793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene.
    Crumly HJ; Pinder RM; Hinshaw WB; Goldberg LI
    Nature; 1976 Feb; 259(5544):584-7. PubMed ID: 1250405
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopaminergic activity of some apomorphine analogs.
    Cheng HC; Long JP; Van Orden LS; Cannon JG; O'Donnell JP
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):89-106. PubMed ID: 968179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine receptors and dopaminergic nerves in the vas deferens of the rat.
    Simon A; Van Maanen EF
    Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):4-15. PubMed ID: 984969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    Johnson AM; Loew DM; Vigouret JM
    Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates.
    Iversen LL; Horn AS; Miller RJ
    Adv Neurol; 1975; 9():197-212. PubMed ID: 167565
    [No Abstract]   [Full Text] [Related]  

  • 7. Adenosine 3',5'-monophosphate content in rat caudate nucleus: demonstration of dopaminergic and adrenergic receptors.
    Forn J; Krueger BK; Greengard P
    Science; 1974 Dec; 186(4169):1118-20. PubMed ID: 4377761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amantadine and apomorphine: interactions on striatal dopamine receptors.
    Cox B
    Proc West Pharmacol Soc; 1975; 18():162-7. PubMed ID: 1237137
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydrolysis of diester prodrugs of apomorphine.
    Baldessarini RJ; Kula NS; Walton KG; Borgman RJ
    Biochem Pharmacol; 1977 Oct; 26(19):1749-56. PubMed ID: 907714
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of dopamine-like compounds on stereotypy and locomotor activity in atropinized rats.
    Grabowska M
    Arch Immunol Ther Exp (Warsz); 1975; 23(6):753-61. PubMed ID: 1241267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-n-propyl-norapomorphine: an extremely potent stimulant of dopamine autoreceptors.
    Argiolas A; Mereu G; Serra G; Melis MR; Fadda F; Gessa GL
    Brain Res; 1982 Jan; 231(1):109-16. PubMed ID: 6799148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. A hypothesis on their mode of interaction with the central dopamine receptor.
    Humber LG; Bruderlein FT; Voith K
    Mol Pharmacol; 1975 Nov; 11(6):833-40. PubMed ID: 1239657
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice.
    Tulunay FC; Sparber SB; Takemori AE
    Eur J Pharmacol; 1975 Aug; 33(1):65-70. PubMed ID: 1175692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apomorphine and amphetamine on schedule-controlled behavior: reversal of tetrabenazine suppression and dopaminergic correlates.
    Butcher LL; Andén NE
    Eur J Pharmacol; 1969; 6(3):255-64. PubMed ID: 5799188
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the dopaminergic effects of apomorphine and (-)-N-n-propylnorapomorphine.
    Menon MK; Clark WG; Neumeyer JL
    Eur J Pharmacol; 1978 Nov; 52(1):1-9. PubMed ID: 569056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of apomorphine action on doapminergic receptors.
    Dandiya PC; Sharma HL; Patni SK; Gambhir RS
    Experientia; 1975 Dec; 31(12):1441-3. PubMed ID: 1213069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic effects of non-hydroxylated rigid analogs of apomorphine.
    Rusterholz DB; Long JP; Flynn JR; Cannon JG; Lee T; Pease JP; Clemens JA; Wong DT; Bymaster FP
    Eur J Pharmacol; 1979 Apr; 55(1):73-82. PubMed ID: 571341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine.
    Hsieh GC; Hollingsworth PR; Martino B; Chang R; Terranova MA; O'Neill AB; Lynch JJ; Moreland RB; Donnelly-Roberts DL; Kolasa T; Mikusa JP; McVey JM; Marsh KC; Sullivan JP; Brioni JD
    J Pharmacol Exp Ther; 2004 Jan; 308(1):330-8. PubMed ID: 14569075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic potency of apomorphine homologues in mice with unilateral lesions of the caudate nucleus.
    Pearl J
    J Pharm Pharmacol; 1978 Feb; 30(2):118-9. PubMed ID: 24097
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.